hiPSC-Neural Stem/Progenitor Cell Transplantation Therapy for Spinal
Cord Injury

Xiaofeng      Du; Asiamah   Ernest   Amponsah; Desheng      Kong; Jingjing      He; Zhenhuan      Ma; Jun      Ma; Huixian      Cui
doi:10.2174/1574888X17666220509222520
Abstract

Spinal cord injury (SCI) is a catastrophic event that incurs substantial personal and social costs. The complex pathophysiology associated with SCI often limits the regeneration of nerve tissue at the injured site and leads to permanent nerve damage. With advances in stem cell biology, the field of regenerative medicine offers the hope of solving this challenging problem. Neural stem/progenitor cells (NSPCs) possess nerve regenerative and neuroprotective effects, and transplanting NSPCs in their optimized form into an injured area holds promising therapeutic potential for SCI. In this review, we summarize the advantages and disadvantages of NSPCs derived from different sources while highlighting the utility of NSPCs derived from induced pluripotent stem cells, an NSPC source with superior advantages, according to data from in vivo animal models and the latest clinical trials.
Keywords: Spinal cord injury, hiPSC, neural stem cell, neural progenitor cell, transplantation, neuroprotective effects.
« Previous Next »
Graphical Abstract

[1]
National Spinal Cord Injury Statistical Center Spinal Cord Facts and Figures 2021. Available from: https://www.nscisc.uab.edu/ Accessed on July 23, 2021

[2]
Bhatnagar T, Liu J, Yung A, et al. Relating histopathology and mechanical strain in experimental contusion spinal cord injury in a rat model. J Neurotrauma  2016; 33(18): 1685-95.
 [http://dx.doi.org/10.1089/neu.2015.4200] [PMID:  26729511]

[3]
Lee BB, Cripps RA, Fitzharris M, Wing PC. The global map for traumatic spinal cord injury epidemiology: Update 2011, global incidence rate. Spinal Cord  2014; 52(2): 110-6.
 [http://dx.doi.org/10.1038/sc.2012.158] [PMID:  23439068]

[4]
Bethel M, Weaver FM, Bailey L, et al. Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders. Osteoporos Int  2016; 27(10): 3011-21.
 [http://dx.doi.org/10.1007/s00198-016-3627-2] [PMID:  27230522]

[5]
Nakashima H, Tetreault LA, Nagoshi N, et al. Does age affect surgical outcomes in patients with degenerative cervical myelopathy? Results from the prospective multicenter AOSpine International study on 479 patients. J Neurol Neurosurg Psychiatry  2016; 87(7): 734-40.
 [http://dx.doi.org/10.1136/jnnp-2015-311074] [PMID:  26420885]

[6]
Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation therapy for spinal cord injury. Nat Neurosci  2017; 20(5): 637-47.
 [http://dx.doi.org/10.1038/nn.4541] [PMID:  28440805]

[7]
Anjum A, Yazid MD, Fauzi Daud M, et al. Spinal cord injury: Pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci  2020; 21(20): 7533.
 [http://dx.doi.org/10.3390/ijms21207533] [PMID:  33066029]

[8]
Katoh H, Yokota K, Fehlings MG. Regeneration of spinal cord connectivity through stem cell transplantation and biomaterial scaffolds. Front Cell Neurosci  2019; 13: 248.
 [http://dx.doi.org/10.3389/fncel.2019.00248] [PMID:  31244609]

[9]
Beattie MS. Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med  2004; 10(12): 580-3.
 [http://dx.doi.org/10.1016/j.molmed.2004.10.006] [PMID:  15567326]

[10]
Hilton BJ, Moulson AJ, Tetzlaff W. Neuroprotection and secondary damage following spinal cord injury: Concepts and methods. Neurosci Lett  2017; 652: 3-10.
 [http://dx.doi.org/10.1016/j.neulet.2016.12.004] [PMID:  27939975]

[11]
Badhiwala JH, Ahuja CS, Fehlings MG. Time is spine: A review of translational advances in spinal cord injury. J Neurosurg Spine  2018; 30(1): 1-18.
 [http://dx.doi.org/10.3171/2018.9.SPINE18682] [PMID:  30611186]

[12]
Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Comp Neurol  2007; 500(2): 267-85.
 [http://dx.doi.org/10.1002/cne.21149] [PMID:  17111361]

[13]
Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord  2003; 41(7): 369-78.
 [http://dx.doi.org/10.1038/sj.sc.3101483] [PMID:  12815368]

[14]
Wang Y, Wang H, Tao Y, Zhang S, Wang J, Feng X. Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience  2014; 266: 91-101.
 [http://dx.doi.org/10.1016/j.neuroscience.2014.02.007] [PMID:  24561219]

[15]
Kwon BK, Grauer JN, Vaccaro AR. The Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J  2005; 4(4): 451-64.
 [http://dx.doi.org/10.1016/j.spinee.2003.07.007]

[16]
Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurg Focus  2008; 25(5): E2.
 [http://dx.doi.org/10.3171/FOC.2008.25.11.E2] [PMID:  18980476]

[17]
Ahuja CS, Wilson JR, Nori S, et al. Traumatic spinal cord injury. Nat Rev Dis Primers  2017; 3: 17018.
 [http://dx.doi.org/10.1038/nrdp.2017.18] [PMID:  28447605]

[18]
Liddelow SA, Barres BA. Reactive astrocytes: Production, function, and therapeutic potential. Immunity  2017; 46(6): 957-67.
 [http://dx.doi.org/10.1016/j.immuni.2017.06.006] [PMID:  28636962]

[19]
Forgione N, Fehlings MG. Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg  2014; 82(3-4): e535-9.
 [http://dx.doi.org/10.1016/j.wneu.2013.01.009] [PMID:  23298675]

[20]
Kwon BK, Fisher CG, Dvorak MF, Tetzlaff W. Strategies to promote neural repair and regeneration after spinal cord injury. Spine  2005; 30(17) (Suppl.): S3-S13.
 [http://dx.doi.org/10.1097/01.brs.0000175186.17923.87] [PMID:  16138063]

[21]
Chaddah R, Arntfield M, Runciman S, Clarke L, van der Kooy D. Clonal neural stem cells from human embryonic stem cell colonies. J Neurosci  2012; 32(23): 7771-81.
 [http://dx.doi.org/10.1523/JNEUROSCI.3286-11.2012] [PMID:  22674254]

[22]
Dessaud E, Ribes V, Balaskas N, et al. Dynamic assignment and maintenance of positional identity in the ventral neural tube by the morphogen sonic hedgehog. PLoS Biol  2010; 8(6), e1000382.
 [http://dx.doi.org/10.1371/journal.pbio.1000382] [PMID:  20532235]

[23]
Kulbatski I, Mothe AJ, Keating A, Hakamata Y, Kobayashi E, Tator CH. Oligodendrocytes and radial glia derived from adult rat spinal cord progenitors: Morphological and immunocytochemical characterization. J Histochem Cytochem  2007; 55(3): 209-22.
 [http://dx.doi.org/10.1369/jhc.6A7020.2006] [PMID:  17101728]

[24]
Mothe AJ, Zahir T, Santaguida C, Cook D, Tator CH. Neural stem/progenitor cells from the adult human spinal cord are multipotent and self-renewing and differentiate after transplantation. PLoS One  2011; 6(11), e27079.
 [http://dx.doi.org/10.1371/journal.pone.0027079] [PMID:  22073257]

[25]
Xu W, Lakshman N, Morshead CM. Building a central nervous system: The neural stem cell lineage revealed. Neurogenesis (Austin)  2017; 4(1), e1300037.
 [http://dx.doi.org/10.1080/23262133.2017.1300037] [PMID:  28516107]

[26]
Xu W, Lakshman N, Morshead CM. Stem cells in the adult CNS revealed: Examining their regulation by myelin basic protein. Neural Regen Res  2016; 11(12): 1916-7.

[27]
Dadwal P, Mahmud N, Sinai L, et al. Activating endogenous neural precursor cells using metformin leads to neural repair and functional recovery in a model of childhood brain injury. Stem Cell Reports  2015; 5(2): 166-73.
 [http://dx.doi.org/10.1016/j.stemcr.2015.06.011] [PMID:  26235894]

[28]
Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol  2005; 23(7): 862-71.
 [http://dx.doi.org/10.1038/nbt1119] [PMID:  16003375]

[29]
Shihabuddin LS, Palmer TD, Gage FH. The search for neural progenitor cells: Prospects for the therapy of neurodegenerative disease. Mol Med Today  1999; 5(11): 474-80.
 [http://dx.doi.org/10.1016/S1357-4310(99)01596-8] [PMID:  10529788]

[30]
Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science  2000; 288(5471): 1660-3.
 [http://dx.doi.org/10.1126/science.288.5471.1660] [PMID:  10834848]

[31]
Hefferan MP, Galik J, Kakinohana O, et al. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation. PLoS One  2012; 7(8), e42614.
 [http://dx.doi.org/10.1371/journal.pone.0042614] [PMID:  22916141]

[32]
Tzeng SF. Neural progenitors isolated from newborn rat spinal cords differentiate into neurons and astroglia. J Biomed Sci  2002; 9(1): 10-6.
 [http://dx.doi.org/10.1007/BF02256573] [PMID:  11810020]

[33]
Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet  1987; 20(3): 263-72.
 [http://dx.doi.org/10.1111/j.1365-2184.1987.tb01309.x] [PMID:  3690622]

[34]
Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA  1999; 96(19): 10711-6.
 [http://dx.doi.org/10.1073/pnas.96.19.10711] [PMID:  10485891]

[35]
Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res  2000; 61(4): 364-70.
 [http://dx.doi.org/10.1002/1097-4547(20000815)61:4<364:AID-JNR2>3.0.CO;2-C] [PMID:  10931522]

[36]
Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature  1981; 292(5819): 154-6.
 [http://dx.doi.org/10.1038/292154a0] [PMID:  7242681]

[37]
Sánchez-Martín FJ, Fan Y, Lindquist DM, Xia Y, Puga A. Lead induces similar gene expression changes in brains of gestationally exposed adult mice and in neurons differentiated from mouse embryonic stem cells. PLoS One  2013; 8(11), e80558.
 [http://dx.doi.org/10.1371/journal.pone.0080558] [PMID:  24260418]

[38]
Azari H, Sharififar S, Rahman M, Ansari S, Reynolds BA. Establishing embryonic mouse neural stem cell culture using the neurosphere assay.  Vis Exp 2011; p. 47.

[39]
Germain N, Banda E, Grabel L. Embryonic stem cell neurogenesis and neural specification. J Cell Biochem  2010; 111(3): 535-42.
 [http://dx.doi.org/10.1002/jcb.22747] [PMID:  20589755]

[40]
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell  2006; 126(4): 663-76.
 [http://dx.doi.org/10.1016/j.cell.2006.07.024] [PMID:  16904174]

[41]
Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell  2007; 131(5): 861-72.
 [http://dx.doi.org/10.1016/j.cell.2007.11.019] [PMID:  18035408]

[42]
Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature  2007; 448(7151): 318-24.
 [http://dx.doi.org/10.1038/nature05944] [PMID:  17554336]

[43]
Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH. Human induced pluripotent stem cells and neurodegenerative disease: Prospects for novel therapies. Curr Opin Neurol  2012; 25(2): 125-30.
 [http://dx.doi.org/10.1097/WCO.0b013e3283518226] [PMID:  22357218]

[44]
Bellenchi GC, Volpicelli F, Piscopo V, Perrone-Capano C, di Porzio U. Adult neural stem cells: An endogenous tool to repair brain injury? J Neurochem  2013; 124(2): 159-67.
 [http://dx.doi.org/10.1111/jnc.12084] [PMID:  23134340]

[45]
Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res  2007; 327(3): 449-62.
 [http://dx.doi.org/10.1007/s00441-006-0308-z] [PMID:  17053900]

[46]
Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison. J Orthop Res  2005; 23(6): 1383-9.
 [http://dx.doi.org/10.1016/j.orthres.2005.03.008.1100230621] [PMID:  15936917]

[47]
Giusto E, Donegà M, Cossetti C, Pluchino S. Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials. Exp Neurol  2014; 260(5): 19-32.
 [http://dx.doi.org/10.1016/j.expneurol.2013.03.009] [PMID:  23507035]

[48]
Sharp J, Frame J, Siegenthaler M, Nistor G, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells  2010; 28(1): 152-63.
 [http://dx.doi.org/10.1002/stem.245] [PMID:  19877167]

[49]
Ruff CA, Wilcox JT, Fehlings MG. Cell-based transplantation strategies to promote plasticity following spinal cord injury. Exp Neurol  2012; 235(1): 78-90.
 [http://dx.doi.org/10.1016/j.expneurol.2011.02.010] [PMID:  21333647]

[50]
Chen KG, Mallon BS, McKay RDG, Robey PG. Human pluripotent stem cell culture: Considerations for maintenance, expansion, and therapeutics. Cell Stem Cell  2014; 14(1): 13-26.
 [http://dx.doi.org/10.1016/j.stem.2013.12.005] [PMID:  24388173]

[51]
Ruzicka J, Machova-Urdzikova L, Gillick J, et al. A comparative study of three different types of stem cells for treatment of rat spinal cord injury. Cell Transplant  2017; 26(4): 585-603.
 [http://dx.doi.org/10.3727/096368916X693671] [PMID:  27938489]

[52]
Amoroso MW, Croft GF, Williams DJ, et al. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci  2013; 33(2): 574-86.
 [http://dx.doi.org/10.1523/JNEUROSCI.0906-12.2013] [PMID:  23303937]

[53]
Lukovic D, Diez Lloret A, Stojkovic P, et al. Highly efficient neural conversion of human pluripotent stem cells in adherent and animal-free conditions. Stem Cells Transl Med  2017; 6(4): 1217-26.
 [http://dx.doi.org/10.1002/sctm.16-0371] [PMID:  28213969]

[54]
Nutt SE, Chang EA, Suhr ST, et al. Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model. Exp Neurol  2013; 248: 491-503.
 [http://dx.doi.org/10.1016/j.expneurol.2013.07.010] [PMID:  23891888]

[55]
Kim DS, Lee DR, Kim HS, et al. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes. PLoS One  2012; 7(7), e39715.
 [http://dx.doi.org/10.1371/journal.pone.0039715] [PMID:  22911689]

[56]
Zhang Y, Pak C, Han Y, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron  2013; 78(5): 785-98.
 [http://dx.doi.org/10.1016/j.neuron.2013.05.029] [PMID:  23764284]

[57]
Patar A, Dockery P, McMahon S, Howard L. Ex vivo rat transected spinal cord slices as a model to assess lentiviral vector delivery of neurotrophin-3 and short hairpin RNA against NG2. Biology (Basel)  2020; 9(3), E54.
 [http://dx.doi.org/10.3390/biology9030054] [PMID:  32183469]

[58]
Abdolahi S, Khodakaram-Tafti A, Aligholi H, et al. Lentiviral vector-mediated transduction of adult neural stem/progenitor cells isolated from the temporal tissues of epileptic patients. Iran J Basic Med Sci  2020; 23(3): 354-61.
 [PMID:  32440322]

[59]
Choi HW, Hong YJ, Kim JS, et al. In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation. PLoS One  2017; 12(1), e0170735.
 [http://dx.doi.org/10.1371/journal.pone.0170735] [PMID:  28141814]

[60]
Zeng H, Guo M, Martins-Taylor K, et al. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One  2010; 5(7), e11853.
 [http://dx.doi.org/10.1371/journal.pone.0011853] [PMID:  20686615]

[61]
Han SS, Williams LA, Eggan KC. Constructing and deconstructing stem cell models of neurological disease. Neuron  2011; 70(4): 626-44.
 [http://dx.doi.org/10.1016/j.neuron.2011.05.003] [PMID:  21609821]

[62]
Kim DS, Lee JS, Leem JW, et al. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev Rep  2010; 6(2): 270-81.
 [http://dx.doi.org/10.1007/s12015-010-9138-1] [PMID:  20376579]

[63]
Kitazawa A, Shimizu N. Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia. N Biotechnol  2011; 28(4): 326-33.
 [http://dx.doi.org/10.1016/j.nbt.2011.03.011] [PMID:  21477670]

[64]
Yang JY, Mumaw JL, Liu Y, Stice SL, West FD. SSEA4-positive pig induced pluripotent stem cells are primed for differentiation into neural cells. Cell Transplant  2013; 22(6): 945-59.
 [http://dx.doi.org/10.3727/096368912X657279] [PMID:  23043799]

[65]
Hester ME, Murtha MJ, Song S, et al. Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol Ther  2011; 19(10): 1905-12.
 [http://dx.doi.org/10.1038/mt.2011.135] [PMID:  21772256]

[66]
Reier PJ. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx  2004; 1(4): 424-51.
 [http://dx.doi.org/10.1602/neurorx.1.4.424] [PMID:  15717046]

[67]
Lepore AC, Walczak P, Rao MS, Fischer I, Bulte JW. MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp Neurol  2006; 201(1): 49-59.
 [http://dx.doi.org/10.1016/j.expneurol.2006.03.032] [PMID:  16764862]

[68]
Kong D, Feng B, Amponsah AE, et al. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice. Stem Cell Res Ther  2021; 12(1): 172.
 [http://dx.doi.org/10.1186/s13287-021-02217-9] [PMID:  33706803]

[69]
Okano H, Yamanaka S. iPS cell technologies: Significance and applications to CNS regeneration and disease. Mol Brain  2014; 7(1): 22.
 [http://dx.doi.org/10.1186/1756-6606-7-22] [PMID:  24685317]

[70]
Ning L, Hu DL, Tao X, Yu SH. Neural stem cells transplantation for the treatment of spinal cord injury. J Clin Rehabil Tissue Eng Res  2011; 15(10): 1809-13.

[71]
Nori S, Okada Y, Yasuda A, et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA  2011; 108(40): 16825-30.
 [http://dx.doi.org/10.1073/pnas.1108077108] [PMID:  21949375]

[72]
Numasawa-Kuroiwa Y, Okada Y, Shibata S, et al. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Reports  2014; 2(5): 648-61.
 [http://dx.doi.org/10.1016/j.stemcr.2014.03.007] [PMID:  24936452]

[73]
Kawabata S, Takano M, Numasawa-Kuroiwa Y, et al. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury. Stem Cell Reports  2016; 6(1): 1-8.
 [http://dx.doi.org/10.1016/j.stemcr.2015.11.013] [PMID:  26724902]

[74]
Lu P, Woodruff G, Wang Y, et al. Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron  2014; 83(4): 789-96.
 [http://dx.doi.org/10.1016/j.neuron.2014.07.014] [PMID:  25123310]

[75]
Kobayashi Y, Okada Y, Itakura G, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One  2012; 7(12), e52787.
 [http://dx.doi.org/10.1371/journal.pone.0052787] [PMID:  23300777]

[76]
Nori S, Okada Y, Nishimura S, et al. Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: Oncogenic transformation with epithelial-mesenchymal transition. Stem Cell Reports  2015; 4(3): 360-73.
 [http://dx.doi.org/10.1016/j.stemcr.2015.01.006] [PMID:  25684226]

[77]
Iida T, Iwanami A, Sanosaka T, et al. Whole-genome DNA methylation analyses revealed epigenetic instability in tumorigenic human iPS cell-derived neural stem/progenitor cells. Stem Cells  2017; 35(5): 1316-27.
 [http://dx.doi.org/10.1002/stem.2581] [PMID:  28142229]

[78]
Okubo T, Iwanami A, Kohyama J, et al. Pretreatment with a γ-secretase inhibitor prevents tumor-like overgrowth in human iPSC-derived transplants for spinal cord injury. Stem Cell Reports  2016; 7(4): 649-63.
 [http://dx.doi.org/10.1016/j.stemcr.2016.08.015] [PMID:  27666789]

[79]
Tanimoto Y, Yamasaki T, Nagoshi N, et al. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation. Stem Cells Transl Med  2020; 9(4): 465-77.
 [http://dx.doi.org/10.1002/sctm.19-0150] [PMID:  31904914]

[80]
Kojima K, Miyoshi H, Nagoshi N, et al. Selective ablation of tumorigenic cells following human induced pluripotent stem cell-derived neural stem/progenitor cell transplantation in spinal cord injury. Stem Cells Transl Med  2019; 8(3): 260-70.
 [http://dx.doi.org/10.1002/sctm.18-0096] [PMID:  30485733]

[81]
Cheol SJ, Nyun KK, Jeehyun Y, et al. Clinical trial of human fetal brain-derived neural stem/progenitor cell transplantation in patients with traumatic cervical spinal cord injury. Neural Plasticity  2015; 2015: 1-22.

[82]
Levi AD, Okonkwo DO, Park P, et al. Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury. Neurosurgery  2018; 82(4): 562-75.
 [http://dx.doi.org/10.1093/neuros/nyx250] [PMID:  28541431]

[83]
Levi AD, Anderson KD, Okonkwo DO, et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma  2019; 36(6): 891-902.
 [http://dx.doi.org/10.1089/neu.2018.5843] [PMID:  30180779]

[84]
Curtis E, Martin JR, Gabel B, et al. A first-in-human, phase i study of neural stem cell transplantation for chronic spinal cord injury. Cell Stem Cell  2018; 22(6): 941-950.e6.
 [http://dx.doi.org/10.1016/j.stem.2018.05.014] [PMID:  29859175]

[85]
Steeves JD, Lammertse D, Curt A, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: Clinical trial outcome measures. Spinal Cord  2007; 45(3): 206-21.
 [http://dx.doi.org/10.1038/sj.sc.3102008] [PMID:  17179972]

[86]
Yang Y, Fan Y, Zhang H, et al. Small molecules combined with collagen hydrogel direct neurogenesis and migration of neural stem cells after spinal cord injury. Biomaterials  2021; 269, 120479.
 [http://dx.doi.org/10.1016/j.biomaterials.2020.120479] [PMID:  33223332]

[87]
Koffler J, Zhu W, Qu X, et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat Med  2019; 25(2): 263-9.
 [http://dx.doi.org/10.1038/s41591-018-0296-z] [PMID:  30643285]

[88]
Liu W, Xu B, Xue W, et al. A functional scaffold to promote the migration and neuronal differentiation of neural stem/progenitor cells for spinal cord injury repair. Biomaterials  2020; 243, 119941.
 [http://dx.doi.org/10.1016/j.biomaterials.2020.119941] [PMID:  32172034]

[89]
Xu B, Zhao Y, Xiao Z, et al. A dual functional scaffold tethered with egfr antibody promotes neural stem cell retention and neuronal differentiation for spinal cord injury repair. Adv Healthc Mater  2017; 6(9), 1601279.
 [http://dx.doi.org/10.1002/adhm.201601279] [PMID:  28233428]
Rights & Permissions Print Cite
Article Metrics
8
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1574888X17666220509222520	Print ISSN 1574-888X
Publisher Name Bentham Science Publisher	Online ISSN 2212-3946
Current Stem Cell Research & Therapy

hiPSC-Neural Stem/Progenitor Cell Transplantation Therapy for Spinal Cord Injury

Abstract Play Pause

Graphical Abstract

Related Books

Abstract
